Climb Bio, Inc. · NASDAQ:CLYM
Pontifax VI G.P. L.P. reported a 7.70% stake in Climb Bio, Inc. (Schedule 13G)
Event Jun 27, 2024 · Filed Sep 18, 2025
Pontifax VI G.P. L.P. reported a 7.70% stake in Climb Bio, Inc., 5,206,380 shares, as a passive investor on Jun 27, 2024. Filed Sep 18, 2025 (Schedule 13G).
- Stake
- 7.70%
- Shares
- 5,206,380
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Pontifax VI G.P. L.P. | 7.70% | 5,206,380 |
| Pontifax Management 4 G.P. (2015) Ltd. | 7.70% | 5,206,380 |
| Ran Nussbaum | 7.70% | 5,206,380 |
| Tomer Kariv | 7.70% | 5,206,380 |
Source
Related
- Climb Bio, Inc.
- Pontifax Management 4 GP (2015) Ltd.
- Climb Bio, Inc. shareholders
- Form 4 · RA Capital Nexus Fund, L.P. · Sep 30, 2026
- Form 4 · Thomas Stephen Basil · Sep 17, 2026
- Schedule 13G/A · Mpm Bioimpact LLC · Aug 14, 2026
- Schedule 13G · FMR LLC · Jul 8, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jul 7, 2026